Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Specialty Generics Market Forecasts to 2028 – Global Analysis By Type (Oral Drugs, Injectables, Topical, Parenteral and Other Types), By Application (Hepatitis C, Multiple Sclerosis, Inflammatory Conditions, Oncology, Cardiovascular, Infectious Diseases, Autoimmune Diseases and Other Applications), By End User and By Geography
... Applications), By End User and By Geography According to Stratistics MRC, the Global Specialty Generics Market is accounted for $69.9 billion in 2022 and is expected to reach $176.6 billion by 2028 growing at a ... Read More
-
Human T-Lymphotropic Virus Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033
... Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on HTLV tests market for ... Read More
-
Clinical Trials Market Analysis and Forecast to 2032: By Phase (Phase I, Phase II, Phase III, and Phase III), Study Design (Interventional Study, Observational Study, and Expanded Access Study), Therapeutic Area (Autoimmune Disease, Oncology, Cardiology, and Others), and Region
... and Others), and Region A clinical trial is a research study that tests a new medical approach, device, medication, or other treatment. Clinical trials are used to determine whether new medical approaches are safe and ... Read More
-
Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End Users (Diagnostic laboratories, Research Institute) - Global Forecast to 2028
... reach USD 4.7 billion by 2028 from USD 3.2 billion in 2023, at a CAGR of 7.4% during the forecast period of 2023 to 2028. Market growth is largely driven by increased prevalence of cancer ... Read More
-
Global Systemic Lupus Erythematosus Market - 2023-2030
... by 2030. The systemic lupus erythematosus market is expected to exhibit a CAGR of 7.3% during the forecast period (2023-2030). Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that can harm the skin, joints, ... Read More
-
Biologics Market
... East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Biologics is a product that is produced from living organisms or contain components of living organisms. Biologics are medicines that are developed ... Read More
-
Global Liver Disease Treatment Market Size study & Forecast, by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, Others) and Regional Analysis, 2022-2029
... Others) and Regional Analysis, 2022-2029 Global Liver Disease Treatment Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the ... Read More
-
Global Oral Transmucosal Drugs Market - 2023-2030
... by 2030. The oral transmucosal drugs market is expected to exhibit a CAGR of 6.4% during the forecast period (2023-2030). Globally, chronic or non-communicable diseases are on the rise and are responsible for 73% of ... Read More
-
Global Difficult-to-Express Proteins Market - 2023-2030
... is expected to exhibit a CAGR of 11.0% during the forecast period (2023-2030). Key strategy acquisitions drive the difficult-to-express proteins market growth. For instance, the acquisition of BioLegend, a top global supplier of life science ... Read More
-
Sjogren’s syndrome- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Sjogren’s ... Read More
-
Antibodies Market, By Drug Type (Monoclonal antibodies, Polyclonal antibodies, Antibody-drug complexes (ADCs), by Disease Indication (CNS Disorders, Cardiovascular, Cancer, Autoimmune Disorders, COVID-19, Others) By End User (Hospitals, Long-term Care Facilities, Research institutes), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Antibodies are used in therapeutic applications for the treatment of diseases such as cancer, autoimmune ... Read More
-
Autoimmune Disease Diagnostics Market Forecasts to 2028 – Global Analysis By Disease Type (Localized Autoimmune Disease, Systemic Autoimmune Disease), Test Type (C-reactive Protein (CRP) Test, Antinuclear Antibody Test, Complete Blood Count (CBC), Urinalysis, Erythrocyte Sedimentation Rate (ESR), Comprehensive Metabolic Panel, Biopsy) and Others
... Rate (ESR), Comprehensive Metabolic Panel, Biopsy) and Others According tStratistics MRC, the Global Autoimmune Disease Diagnostics Market is accounted for $1198.9 billion in 2022 and is expected treach $1966.8 billion by 2028 growing at a ... Read More
-
Immunoglobulins: Global Market Outlook
... report surveys the competitive landscape, market dynamics and current and developing technologies. The report also analyzes the impact of COVID-19 on the market. In terms of geographical regions, the report analyzes the market across North ... Read More
-
In-vitro Diagnostics Market - By Product (Reagents & Kits, Instruments), By Test (Clinical Chemistry, Immunoassay, Hematology, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Pharmacogenomics), By End-user (Hospitals, Diagnostic Laboratories) & Forecast, 2023 - 2032
... 2023 - 2032 In-vitro Diagnostics Market is anticipated to grow significantly from 2023 to 2032, owing to the constant improvements in the healthcare infrastructure and the increasing number of government and privately owned pathology labs. ... Read More
-
Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
... Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others) The biopharmaceuticals market is expected to grow from US$ 3,29,966.22 ... Read More
-
Middle East & Africa Injection Pen Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
... and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others) The Middle East & Africa injection pen market is expected to grow from US$ 2,016.10 million in 2022 to US$ 2,872.94 million ... Read More
-
South America Injection Pen Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
... Therapy), and End User (Hospitals and Clinics, Home Care, and Others) The South America injection pen market is expected to grow from US$ 2,389.84 million in 2022 to US$ 3,467.89 million by 2028. It is ... Read More
-
Europe Injection Pen Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
... and End User (Hospitals and Clinics, Home Care, and Others) The Europe injection pen market is expected to grow from US$ 11,194.60 million in 2022 to US$ 16,749.04 million by 2028. It is estimated to ... Read More
-
North America Injection Pen Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
... Therapy), and End User (Hospitals and Clinics, Home Care, and Others) The North America injection pen market is expected to grow from US$ 13,156.60 million in 2022 to US$ 20,075.51 million by 2028. It is ... Read More
-
Global Biologicals for Systemic Lupus Erythematosus Market Growth (Status and Outlook) 2023-2029
... for Systemic Lupus Erythematosus sales in 2022, providing a comprehensive analysis by region and market sector of projected Biologicals for Systemic Lupus Erythematosus sales for 2023 through 2029. With Biologicals for Systemic Lupus Erythematosus sales ... Read More
-
Global Glucocorticoid for Systemic Lupus Erythematosus Market Growth (Status and Outlook) 2023-2029
... for Systemic Lupus Erythematosus sales in 2022, providing a comprehensive analysis by region and market sector of projected Glucocorticoid for Systemic Lupus Erythematosus sales for 2023 through 2029. With Glucocorticoid for Systemic Lupus Erythematosus sales ... Read More
-
Global Immunosuppressant for Systemic Lupus Erythematosus Market Growth (Status and Outlook) 2023-2029
... for Systemic Lupus Erythematosus sales in 2022, providing a comprehensive analysis by region and market sector of projected Immunosuppressant for Systemic Lupus Erythematosus sales for 2023 through 2029. With Immunosuppressant for Systemic Lupus Erythematosus sales ... Read More
-
Asia-Pacific Injection Pen Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
... and End User (Hospitals and Clinics, Home Care, and Others) The Asia-Pacific injection pen market is expected to grow from US$ 11,116.23 million in 2022 to US$ 17,161.96 million by 2028. It is estimated to ... Read More
-
Systemic Lupus Erythematosus and Lupus Nephritis Epidemiology Analysis and Forecast, 2021-2031
... life-threatening illness (Tsokos, 2011). In SLE, the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs (Centers for Disease Control and Prevention, 2022). SLE is also referred to ... Read More
-
Lupus Nephritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Lupus Nephritis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
Research Assistance
